243 related articles for article (PubMed ID: 2934406)
1. Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.
Schifferli JA; Steiger G; Hauptmann G; Spaeth PJ; Sjöholm AG
J Clin Invest; 1985 Dec; 76(6):2127-33. PubMed ID: 2934406
[TBL] [Abstract][Full Text] [Related]
2. Control of immune complexes by the classical pathway.
Whaley K; Ahmed AE
Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
[TBL] [Abstract][Full Text] [Related]
3. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
4. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K
Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
6. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
Schifferli JA; Woo P; Peters DK
Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
[TBL] [Abstract][Full Text] [Related]
7. Complement, antigen-antibody complexes and immune complex disease.
Naama JK; Niven IP; Zoma A; Mitchell WS; Whaley K
J Clin Lab Immunol; 1985 Jun; 17(2):59-67. PubMed ID: 2931531
[No Abstract] [Full Text] [Related]
8. [Elimination of immune complexes: role of complement].
Schifferli JA
Schweiz Med Wochenschr; 1985 Oct; 115(41):1422-4. PubMed ID: 2933806
[TBL] [Abstract][Full Text] [Related]
9. Immune complex modulation by plasma proteins. With special reference to the complement system and autoimmune diseases.
Baatrup G
Dan Med Bull; 1989 Oct; 36(5):443-63. PubMed ID: 2530063
[TBL] [Abstract][Full Text] [Related]
10. Reduced complement-mediated immune complex solubilization in leprosy patients.
Ramanathan VD; Sharma P; Ramu G; Sengupta U
Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
[TBL] [Abstract][Full Text] [Related]
11. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
Kerr MA; Wilton E; Naama JK; Whaley K
Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
[TBL] [Abstract][Full Text] [Related]
13. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
14. Prevention of immune precipitation by purified components of the alternative pathway.
Naama JK; Holme E; Hamilton E; Whaley K
Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
[TBL] [Abstract][Full Text] [Related]
15. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
16. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
19. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
Balestrieri G; Pagani D; Tincani A
J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
